MSLI : Summary for Merus Labs International Inc. - Yahoo Finance

U.S. Markets open in 9 hrs 16 mins

Merus Labs International Inc. (MSLI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.76-0.01 (-1.47%)
At close: 4:00PM EDT
People also watch
PRPHNEPTMNOVMTSLMEIP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.77
Open0.76
Bid0.00 x
Ask3.37 x 400
Day's Range0.76 - 0.78
52 Week Range0.70 - 1.76
Volume320
Avg. Volume19,272
Market Cap89.74M
BetaN/A
PE Ratio (TTM)-7.84
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Merus Labs International, Inc. :MSLI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017
    Capital Cubelast month

    Merus Labs International, Inc. :MSLI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis Merus Labs International, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Merus Labs International, Inc. – OncoMed Pharmaceuticals, Inc. and Ohr Pharmaceutical, Inc. (OMED-US and OHRP-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • CNW Grouplast month

    Merus Labs Announces Changes to Stock Option Plan to Address ISS Recommendation

    Merus Labs Announces Changes to Stock Option Plan to Address ISS Recommendation

  • PR Newswirelast month

    Merus Labs Announces Changes to Stock Option Plan to Address ISS Recommendation

    TORONTO, March 13, 2017 /PRNewswire/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] announces that the board of directors of the Company has approved minor amendments to its stock option plan (the "Plan").  The amendments have been proposed to address issues raised by Institutional Shareholder Services ("ISS") in the course of its review of the matters to be voted on at the upcoming annual and special meeting of the shareholders of Merus to be held on March 21, 2017 (the "AGM").  The changes to the Plan address what the Company understands were the "overriding factors" that resulted in ISS issuing a negative recommendation on approval of the continuation of the Plan. The amendments to the Plan also address certain "housekeeping" changes requested by the TSX.